AbstractEts-1 is a cellular homologue of the product of the viral ets oncogene of the E26 virus, and it functions as a tissue-specific transcription factor. It plays an important role in cell proliferation, differentiation, lymphoid cell development, transformation, angiogenesis, and apoptosis. Ets-1 controls the expression of critical genes involved in these processes by binding to ets binding sites present in the transcriptional regulatory regions. Here, we transiently overexpressed Ets-1 in MCF-7 and comprehensively searched for potential downstream targets of Ets-1 by cDNA microarray analysis. The expressions of several interferon-related genes including STAT1 and Nmi were augmented by the overexpression of Ets-1. RT-PCR and Western blo...
International audienceEts-1 transcription factor overexpression in breast cancers is associated with...
The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matr...
Oestrogen receptor-positive (ER+) breast cancer accounts for over three quarters of all diagnosed br...
Breast cancer is highly aggressive and is the leading cause of cancer-related mortality in women in ...
The purpose of this study was to explore the role of transcription factor Ets1 in estrogen receptor ...
ETS1 has shown dichotomous roles as an oncogene and a tumor suppressor gene in diverse cancers, but ...
International audienceEts-1 overexpression in human breast cancers is associated with invasiveness a...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
International audienceAcquisition of invasive characteristics is a hallmark of breast carcinoma prog...
Transcription factors are an important group of proteins. Changes in expression or activity of trans...
E26 transformation specific (Ets) proteins are a versatile class of transcription factors. They act ...
The transcription factor ETV7 is an oncoprotein that is up-regulated in all breast cancer (BC) types...
Les facteurs ETV1, 4, 5 sont souvent associée au développement de cancers. Le 1èr projet porte sur ...
Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous disease of significant mortality an...
Background\ud Clinical resistance to chemotherapeutic agents is one of the major hindrances in the t...
International audienceEts-1 transcription factor overexpression in breast cancers is associated with...
The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matr...
Oestrogen receptor-positive (ER+) breast cancer accounts for over three quarters of all diagnosed br...
Breast cancer is highly aggressive and is the leading cause of cancer-related mortality in women in ...
The purpose of this study was to explore the role of transcription factor Ets1 in estrogen receptor ...
ETS1 has shown dichotomous roles as an oncogene and a tumor suppressor gene in diverse cancers, but ...
International audienceEts-1 overexpression in human breast cancers is associated with invasiveness a...
This article is hosted on a website external to the CBCRA Open Access Archive. Selecting “View/Open...
International audienceAcquisition of invasive characteristics is a hallmark of breast carcinoma prog...
Transcription factors are an important group of proteins. Changes in expression or activity of trans...
E26 transformation specific (Ets) proteins are a versatile class of transcription factors. They act ...
The transcription factor ETV7 is an oncoprotein that is up-regulated in all breast cancer (BC) types...
Les facteurs ETV1, 4, 5 sont souvent associée au développement de cancers. Le 1èr projet porte sur ...
Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous disease of significant mortality an...
Background\ud Clinical resistance to chemotherapeutic agents is one of the major hindrances in the t...
International audienceEts-1 transcription factor overexpression in breast cancers is associated with...
The transcription factor Ets-1 regulates the expression of several angiogenic and extracellular matr...
Oestrogen receptor-positive (ER+) breast cancer accounts for over three quarters of all diagnosed br...